| | 129311-55-3 Basic information More.. |
| Product Name: | Ganirelix | | Synonyms: | N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-[bis(ethylaMino)Methylene]-D-lysyl-L-leucyl-N6-[bis(ethylaMino)Methylene]-L-lysyl-L-prolyl-;Ganirelix acetate salt;N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-[bis(ethylamino)methylene]-D-lysyl-L-leucyl-N6-[bis(ethylamino)methylene]-L-lysyl-L-prolyl-D-alaninamide diacetate;183552-38-7 (free base);GANIRELIX (ACETATE);183552-38-7 (FREE BASE);Ganirelix USP/EP/BP;Ganirelix Diacetate salt | | CAS: | 129311-55-3 | | MF: | C80H113ClN18O13 | | MW: | 1570.31902 | | EINECS: | | | Mol File: | 129311-55-3.mol |  |
Use
Ganirelix acetate was introduced in germany as prefilled syringes for subcutaneous injections that inhibit premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation. this decapeptide analog of luteinizing hormonereleasing hormone (lh-rh) is the second third-generation lh-rh antagonist to be launched after citrorelix (asta medica). this highly bioavailable compound immediately blocks the endogenous release by the pituitary gland of luteinizing hormone (lh) and follicle-stimulating hormone (fsh), the hormone that induces ovulation. after discontinuation of the treatment, the pituitary-gonadal function is rapidly recovered due to its short-half life.
- Ganirelix Acetate
-
- US $0.00 / g
- 2024-08-22
- CAS:129311-55-3
- Min. Order: 1g
- Purity: 98%min
- Supply Ability: 1000g
- Ganirelix Acetate
-
- US $30.00 / KG
- 2023-07-19
- CAS:129311-55-3
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 20 Tons
- Ganirelix
-
- US $7.00 / KG
- 2020-02-14
- CAS:129311-55-3
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100kg
|
|
129311-55-3
Recommend Suppliers |
|